Patients experience significant burdens (fear, discomfort, disruptions to their lives) with geographic atrophy (GA) treatments that are dosed monthly or every other month via needle injections into the eye. Hear GA insights from Elias Reichel, M.D. at https://bit.ly/3OMMPkt $AKTX